Fuse Oncology Announces at ASTRO 2023: Integrated Oncology Network (ION) will Begin Implementing S!GNAL Software Following a Highly Successful Trial Demonstrating Measurable Value

Underscores the transformative power of S!GNAL at clinical and enterprise levels BOONE, N.C. and NASHVILLE, Tenn., Oct. 1, 2023 /PRNewswire/ -- Integrated Oncology Network (ION) is implementing Fuse Oncology's (Fuse) groundbreaking product, S!GNAL, across its extensive network, following...